# Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma

> **NCT00554905** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 180 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cancer

## Interventions

- **PROCEDURE:** Radiofrequency ablation
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT00554905
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2009-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554905, "Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00554905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*